CHILDREN'S HOSPITAL MEDICAL CENTER OF AKRON Patent applications |
Patent application number | Title | Published |
20160085933 | CLINICAL COMPONENT ROUTING SYSTEM - One or more techniques and/or systems are disclosed for a system that may be used for managing routing of clinical operation component lines. A first communication coupling component can selectably receive a first connector that is engaged with a first communication bus connected to a first part of a first clinical operation component. A second communication coupling component can selectably receive a second connector that is engaged with a second communication bus connected to a second part of the first clinical operation component. A bus routing component is connected to the first receptacle and the second receptacle, and the bus routing component comprises a third communication bus that is used to communicatively couple the first connector and the second connector, resulting in communicatively coupling the second part with the first part of the first clinical operation component. | 03-24-2016 |
20110112884 | Method and Apparatus for Determining Appropriate Health Care Staffing - Provided is a method for making a schedule of a first number of people needed to staff a health care department for a first time period. The method may comprise defining a first time period, defining a second time period, providing admission numbers, providing residence numbers, predicting a total admission number for the second time period, predicting admission numbers for each of a plurality of acuity levels for the first time period, predicting residence numbers for each acuity level for the first time period, predicting the first number of people, and outputting a schedule of the first number of people in the first time period. | 05-12-2011 |
20090155794 | CLONING MULTIPLE CONTROL SEQUENCES INTO CHROMOSOMES OR INTO ARTIFICIAL CENTROMERES - Artificially synthesizing 29 homozygous cystic fibrosis core panel controls demonstrates placing multiple homozygous mutant sequences on the same single control DNA sequence to streamline quality control by minimizing extra control assays, time, and costly formatted test materials and testing all controls during every test. Any rare or unavailable reported DNA sequence can be PCR amplified using primer pairs synthesized with the designated mutation or variant sequence with paired adjacent upstream and downstream primers to amplify target sequences in total genomic DNA. | 06-18-2009 |